Editor-in-Chief
- Alan Storey, Weatherall Institute of Molecular Medicine, University of Oxford
Articles
-
Research
Molecular Cancer 2013, 12:47 (24 May 2013)The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line
-
Research
Molecular Cancer 2013, 12:46 (24 May 2013)Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia
-
Research
Molecular Cancer 2013, 12:45 (24 May 2013)Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
-
Research
Molecular Cancer 2013, 12:44 (21 May 2013)Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells
-
Review
Molecular Cancer 2013, 12:43 (19 May 2013)The MicroRNA-148/152 Family: Multi-faceted Players
-
Research
-
Research
Molecular Cancer 2013, 12:41 (13 May 2013)Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling
-
Research
-
Research
Molecular Cancer 2013, 12:39 (9 May 2013)6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
-
Short communication
Molecular Cancer 2013, 12:38 (7 May 2013)Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway
-
Research
Molecular Cancer 2013, 12:37 (4 May 2013)Molecular changes induced by the curcumin analogue D6 in human melanoma cells
-
Short communication
Molecular Cancer 2013, 12:36 (4 May 2013)Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation
- View more articles
Aims & scope
Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Latest review
Latest news
- 22 May 2013
- Over 75s with RCC represent unique subpopulation
- 22 May 2013
- Laparoscopy viable for local RCC relapse
- 13 May 2013
- Excess deaths among seminoma patients persist
- 08 May 2013
- Thalidomide fails to boost mesothelioma outcomes
Author profile
Professor Wei Zhang is the Director of the Cancer Genomics Core Lab at the M D Anderson Cancer Center.
"It has become clear that BioMed Central is managed by able Editors who maintain a high standard for published articles. This should boost the confidence of any scientist and encourage them to submit their good work to BioMed Central journals for publication, where they their studies can be read for free by a broad range of readers".
Email updates
Receive periodic news and updates relating to this journal straight to your inbox.
Indexed by
- BIOSIS
- CAS
- Current contents
- Embase
- Google Scholar
- MEDLINE
- PubMed
- PubMed Central
- Science Citation Index Expanded
- Scopus


RSS
Comments
View more comments